Track RNAZ and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
RNAZ - Transcode Therapeutics Inc (RNAZ) has a earnings per share of -$5.82, up 96.1% over the past year.
Latest EPS (Actual)
-$5.82
Beat Rate
16.7%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Nov 2025 | -$1.02 | -$5.82 | Miss | -470.59% |
| Aug 2025 | -$1.64 | -$5.13 | Miss | -212.80% |
| Apr 2025 | -$89.88 | -$1,286.15 | Miss | -1330.96% |
| Mar 2025 | -$89.88 | -$1,286.15 | Miss | -1330.96% |
| Nov 2024 | -$452.76 | -$147.84 | Beat | +67.35% |
| Aug 2024 | -$21,436.81 | -$27,350.42 | Miss | -27.59% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.